Erleva 150 mg Tablet

About Erleva 150 mg Tablet

Erleva 150 mg Tablet is a targeted therapy designed to combat specific types of cancer, primarily non-small cell lung cancer (NSCLC) and pancreatic cancer. Its active ingredient, erlotinib, works by inhibiting the growth of cancer cells by blocking the epidermal growth factor receptor (EGFR), a protein that promotes cell proliferation. This action helps to slow down or stop the spread of cancer, providing a crucial treatment option for patients battling these aggressive forms of the disease. While Erleva can be effective, its important to be aware of potential side effects, including skin rash, diarrhea, and liver function changes, which may require monitoring during treatment. Patients should also inform their healthcare provider of any pre-existing conditions or medications to avoid adverse interactions. As with any cancer treatment, adherence to the prescribed regimen and regular follow-up appointments are essential for optimal results. If you or a loved one are facing a cancer diagnosis, consult your healthcare professional to see if Erleva 150 mg Tablet could be a suitable part of your treatment plan.